Harmony Biosciences Holdings, Inc. HRMY Business Segments — Income Tax Expense Benefit

Similar metrics at other companies

KRYSReportable Segment — Income Tax Expense (Benefit)

$5.51M-29.9%

PNW

PNWOther — Income Tax Expense (Benefit)

$7M+133%

PTCTLife Science — Income Tax Expense Benefit

$347K-99.5%

BHFLife — Income Tax Expense (Benefit)

-$2M-300%

SYREIncome Tax

$0+100%

RWTRedwood Investments — Income Tax Expense (Benefit)

$1.37M+552%

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s business segments — income tax expense benefit?

Harmony Biosciences Holdings, Inc. (HRMY) reported business segments — income tax expense benefit of $7.2M in Q1 2026.

How has Harmony Biosciences Holdings, Inc.'s business segments — income tax expense benefit changed year-over-year?

Harmony Biosciences Holdings, Inc.'s business segments — income tax expense benefit decreased by 38.0% year-over-year, from $11.62M to $7.2M.

What is the long-term trend for Harmony Biosciences Holdings, Inc.'s business segments — income tax expense benefit?

Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s business segments — income tax expense benefit has grown at a -9.8% compound annual growth rate (CAGR), from -$76.78M to $56.38M.

What does business segments — income tax expense benefit mean?

This reflects the net tax impact on the segment's earnings, including both current tax provisions and deferred tax benefits. It is a critical component in determining the segment's contribution to the company's overall net profitability and effective tax rate.